In GSE31161 sample set, increased SETDB1 expression was observed in relapsed MM patients when compared to baseline expression in the TT2 group; however, there was no difference in the TT3 group (Figure 3(a), TT2 p < 0.05; TT3 p = 0.94, Wilcoxon test). Here, SETDB1 is linked to Miyoshi myopathy.